Jai Sivanandan Nagarajan
@jai_sivanandan
Followers
182
Following
2K
Media
15
Statuses
133
PGY2 Internal Medicine @UpstateIM_res @UpstateNews | Alumni @SRM_Univ | Aspiring Cardiologist🫀| Views are my own
Syracuse, NY
Joined November 2013
We matched our top 4 candidates for 4 positions at our cardiovascular disease fellowship program. Congratulations Rahul, Ritu, Ryan and Victor! Well-deserved and welcome to Upstate! #cardiotwitter #medtwitter
0
5
120
1/ 🚨 NEW episode on venous congestion & the VExUS score 💧 Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️ 🖥️: https://t.co/CeJBrZr3qr
3
65
197
Excited to share my second interview with @AJMC_Journal from #ASPC2025! 🫀 Grateful to @ASPCardio for the opportunity to present our work and to @AJMC_Journal for highlighting it! @womenincardiol1
https://t.co/0F67DIU5Tv
ajmc.com
SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on cardiotoxicity, explains Rakendu Rajendran, MBBS.
0
3
12
Congratulations @rohan_ochani and team for winning Paul Dudley White International Scholar Award #AHA25
Our work on clinical efficacy of telemedicine vs standard outpatient mgmt in HF patients, presented at AHA 2025 Scientific Sessions, has won the 🏆 Paul Dudley White International Scholar Award! Outstanding work and collaboration with @saifsyeddr
@UpstateIM_Res
@UpstateCardiol1
1
1
9
VESALIUS-CV Evolocumab improves CV outcomes in high risk primary prevention and secondary prevention without prior event. My take⬇️ #LateBreakers #AHA2025 @NEJM
https://t.co/JRFjA6Qeqo
1
21
79
0
0
8
Amazed to see @DLBHATTMD in person at #AHA25 talk about TRANQUILITY trial- IL-6 inhibitior pacibekitug leading to reductions in hs-CRP @AHAScience
0
6
53
Happy to have presented 2 moderated presentation and a poster at #AHA2025 @AHAScience @UpstateIM_Res @UpstateCardiol1
@mhanifMD @rohan_ochani @__oldwine @RakenduJR
3
5
19
DECAF: In an open-label multi-national RCT of N=200 pts with persistent AF consuming avg ~1cup coffee per day, maintaining coffee consumption led to *reduced* AF/AFL recurrence vs abstinence! https://t.co/myl9ugiUpq
@JAMA_current @gregorymmarcus #AHA25 ☕️
3
38
133
Amazed to see @DLBHATTMD in person at #AHA25 talk about TRANQUILITY trial- IL-6 inhibitior pacibekitug leading to reductions in hs-CRP @AHAScience
0
1
10
Looking forward to AHA scientific sessions at New Orleans this weekend #AHA2025 @UpstateIM_Res @UpstateCardiol1
2
0
7
🫵 Come learn more about post-CABG racial disparities in our cohort study at Station 8 at Noon 🕛 today! 🫀 #TCT2025
0
1
3
Please join me at 4:20 pm at Station 2- I’m excited to present our work, Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes. https://t.co/dPIy67aKav
#TCT2025 @crfheart @TCTConference
1
2
15
I wouldn’t exactly call myself a black belt in beta-blockers, but with all this talk of superiority, "non-superiority," and "non-non-inferiority," it’s really enough to get confused. If I interpret correctly the avalanche of trials from the past year, accompanied by the
3
56
224
0
0
0